NCT06445166 2026-04-06
Propranolol for the Treatment of Kaposi Sarcoma in Adults
Washington University School of Medicine
Phase 2 Recruiting
Clinical Trials
25 trialsNCT04848519 2026-02-19
Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma
Emory University
Phase 2 Active not recruiting
NCT05741164 2026-02-17
Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer
Emory University
Phase 2 Not yet recruiting
NCT05451043 2025-06-26
Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
AHS Cancer Control Alberta
Phase 2 Recruiting
NCT03152786 2025-02-17
Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
Wake Forest University Health Sciences
Phase 2 Terminated
NCT06775080 2025-01-14
The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors
Huashan Hospital
Phase 2 Recruiting
NCT05679193 2024-05-29
PeP-RALP
Oslo University Hospital
Phase 2 Completed
NCT02641314 2024-05-10
METRO-NB2012
University of Cologne
Phase 2 Completed
NCT03474614 2024-04-19
Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation
St. Joseph's Hospital and Medical Center, Phoenix
Phase 2 Terminated
NCT06145074 2024-03-28
IMPULS
Zealand University Hospital
Phase 2 Recruiting
NCT04518124 2023-11-22
Propranolol in Angiosarcoma
The Netherlands Cancer Institute
Phase 2 Completed
NCT05961761 2023-07-27
PROPANE
Herlev and Gentofte Hospital
Phase 2 Recruiting
NCT03589014 2022-02-25
Treat_CCM
Mario Negri Institute for Pharmacological Research
Phase 2 Completed
NCT01847001 2021-09-10
Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
Columbia University
Phase 2 Completed
NCT02420223 2021-06-07
Study of Propranolol to Decrease Gene Expression of Stress-Mediated Beta-Adrenergic Pathways in HCT Recipients
Medical College of Wisconsin
Phase 2 Completed
NCT04493489 2020-07-30
Propranolol Adjuvant Treatment of Bladder Cancer
Central South University
Phase 2 Unknown
NCT04005365 2019-11-26
Clinical Study of Propranolol Combined With Neoadjuvant Chemotherapy in Gastric Cancer
Central South University
Phase 2 Unknown
NCT01988831 2019-05-10
Efficacy of Propranolol Treatment to Prevent Melanoma Progression
University Hospital, Geneva
Phase 2 Suspended
NCT03323710 2019-01-09
Study of Propranolol Plus Sunitinib in First-line Treatment of Metastatic Renal Cell Carcinoma
Military Institute od Medicine National Research Institute
Phase 2 Withdrawn
NCT01074437 2018-10-04
Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)
Seattle Children's Hospital
Phase 2 Terminated
NCT02596867 2018-03-01
NPBC
Texas Tech University Health Sciences Center, El Paso
Phase 2 Terminated
NCT02104011 2018-01-23
STBETA
University Hospital, Bordeaux
Phase 2 Completed
NCT01705392 2017-02-24
Bevacizumab vs Dacarbazine in Metastatic Melanoma
Haukeland University Hospital
Phase 2 Terminated
NCT00967226 2016-02-24
Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas
Children's National Research Institute
Phase 2 Terminated
NCT01072045 2014-12-02
Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma
University of Sao Paulo
Phase 2 Completed